Methodology

All entries for: AstraZeneca Pharmaceuticals LP

February 20, 2026

AstraZeneca Pharmaceuticals LP

Orphan Drug Designation

treatment of follicular lymphoma

Disease Area: Rare Disease
Source
February 2, 2026

AstraZeneca Pharmaceuticals LP

Orphan Drug Designation

treatment of malignant glioma

Disease Area: Rare Disease
Source
Source
November 9, 2025

AstraZeneca Pharmaceuticals LP

Orphan Drug Designation

FDA orphan drug designation: treatment of acute lymphocytic leukemia

Disease Area: Rare Diseases
Source
Source
Scroll to Top